Debiopharm International Sa

This study is testing a new, long-acting injection called Debio 4326 that children would receive just once a year. It aims to safely and effectively delay early puberty in 56 children aged 2 to 10 who have central precocious puberty. The main goal is to see if the injection can k…

This is an early-stage study to find a safe dose of a new oral drug called Debio 0123 for adults with advanced solid tumors that have come back or stopped responding to standard treatments. The first part of the study will determine the highest dose patients can tolerate. The sec…

This early-stage study is testing a new oral drug called Debio 0123 in combination with two standard chemotherapy drugs (carboplatin and etoposide). It aims to find a safe dose and see if the combination can help control tumors in adults whose small cell lung cancer has returned …